What is NDC 70518-2095?

70518-2095 is the product NDC for Trifluoperazine Hydrochloride, Trifluoperazine hydrochloride 2 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.

REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Trifluoperazine Hydrochloride?

23 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Trifluoperazine Hydrochloride NDC 70518-2095

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-2095Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-2095Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-2095-0	7051820950070518209500	30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2095-0)Marketed from May 21, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trifluoperazine Hydrochloride
Generic name (nonproprietary): trifluoperazine hydrochloride
Active ingredients: Trifluoperazine hydrochloride — 2 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.NDC labeler code 70518
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040209
Marketing start: May 21, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 70518-2095_499dd16d-513b-780e-e063-6294a90a0230SPL ID 499dd16d-513b-780e-e063-6294a90a0230SPL set ID 339ceb53-3b1c-459f-84eb-77bd4315c998RxCUI 198324UNII 6P1Y2SNF5V
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518209500 followed by a unit qualifier and the quantity

Package 70518-2095-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the management of schizophrenia. Trifluoperazine hydrochloride tablets, USP are effective for the short-term treatment of generalized non-psychotic anxiety. However, trifluoperazine hydrochloride tablets are not the first drug to be used in therapy for most patients with non-psychotic anxiety because certain risks associated with its use are not shared by common alternative treatments (i.e., benzodiazepines). When used in the treatment of non-psychotic anxiety, trifluoperazine hydrochloride tablets should not be administered at doses of more than 6 mg per day or for longer than 12 weeks because the use of trifluoperazine hydrochloride tablets at higher doses or for …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-2095

What is NDC 70518-2095?: 70518-2095 is the product NDC for Trifluoperazine Hydrochloride, Trifluoperazine hydrochloride 2 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Trifluoperazine Hydrochloride.
What is the active ingredient?: Trifluoperazine hydrochloride.
Who is the labeler?: REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Trifluoperazine Hydrochloride?: 23 other product NDCs are listed under this name. See all Trifluoperazine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Trifluoperazine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4686	70518-4686-00
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 1 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-140	48433-0140-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-141	48433-0141-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-142	48433-0142-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 10 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-143	48433-0143-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4554	70518-4554-00
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-2106	70518-2106-00
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 1 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-572	51079-0572-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-573	51079-0573-20
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-574	51079-0574-20

All 24 Trifluoperazine Hydrochloride NDCs

Other NDCs under ANDA 040209

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040209
Product	Strength	Form · route	Labeler	Product NDC
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 1 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-2401
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-2402
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-2405
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 10 mg/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	0378-2410
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 1 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-140
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-141
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-142
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 10 mg/1	Tablet, Film coatedOral	Safecor Health LLC	48433-143
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 1 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-572
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 2 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-573
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-574
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 10 mg/1	Tablet, Film coatedOral	Mylan Institutional Inc.	51079-575
Trifluoperazine Hydrochloride	Trifluoperazine hydrochloride 5 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-2106